1-ethyl-2-methyl-3-hydroxypyridin-4-one and pyromeconic acid

1-ethyl-2-methyl-3-hydroxypyridin-4-one has been researched along with pyromeconic acid in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dobbin, PS; Hall, AD; Hider, RC; Porter, JB; Sarpong, P; Taylor, PD; van der Helm, D; Xiao, G	1
Cohen, SM; Fullagar, JL; Jacobsen, JA; Miller, MT	1

Other Studies

2 other study(ies) available for 1-ethyl-2-methyl-3-hydroxypyridin-4-one and pyromeconic acid

Article	Year
Synthesis, physicochemical properties, and biological evaluation of N-substituted 2-alkyl-3-hydroxy-4(1H)-pyridinones: orally active iron chelators with clinical potential. Journal of medicinal chemistry, 1993, Aug-20, Volume: 36, Issue:17 Topics: Administration, Oral; Animals; Crystallography; Deferoxamine; Horses; Humans; Iron; Iron Chelating Agents; Liver; Mice; Pyridones; Rats; Stereoisomerism; Structure-Activity Relationship	1993
Identifying chelators for metalloprotein inhibitors using a fragment-based approach. Journal of medicinal chemistry, 2011, Jan-27, Volume: 54, Issue:2 Topics: Antigens, Bacterial; Bacterial Toxins; Chelating Agents; Copper; Drug Design; Humans; Hydroxyquinolines; Iron; Ligands; Lipoxygenase Inhibitors; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases; Monophenol Monooxygenase; Nitric Oxide Synthase Type II; Recombinant Proteins; Small Molecule Libraries; Structure-Activity Relationship; Sulfonamides; Zinc	2011

Article

Year

Synthesis, physicochemical properties, and biological evaluation of N-substituted 2-alkyl-3-hydroxy-4(1H)-pyridinones: orally active iron chelators with clinical potential.

Journal of medicinal chemistry, 1993, Aug-20, Volume: 36, Issue:17

Topics: Administration, Oral; Animals; Crystallography; Deferoxamine; Horses; Humans; Iron; Iron Chelating Agents; Liver; Mice; Pyridones; Rats; Stereoisomerism; Structure-Activity Relationship

1993

Identifying chelators for metalloprotein inhibitors using a fragment-based approach.

Journal of medicinal chemistry, 2011, Jan-27, Volume: 54, Issue:2

Topics: Antigens, Bacterial; Bacterial Toxins; Chelating Agents; Copper; Drug Design; Humans; Hydroxyquinolines; Iron; Ligands; Lipoxygenase Inhibitors; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases; Monophenol Monooxygenase; Nitric Oxide Synthase Type II; Recombinant Proteins; Small Molecule Libraries; Structure-Activity Relationship; Sulfonamides; Zinc

2011